Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Projects
Showing entries 6 - 10 out of 15

Open PHACTS

Ecker, G. (Project Lead) & Dangl, A. (Admin)

1/03/1128/02/16

Project: Research funding


K4DD

Ecker, G. (Project Lead), Grandits, M. (Co-Lead) & Dangl, A. (Admin)

1/11/1231/10/17

Project: Research funding


Liganden für das alpha+/ beta-

Ecker, G. (Project Lead)

3/12/143/12/17

Project: Research funding


EU-ToxRisk: EU-ToxRisk

Ecker, G. (Project Lead), Grandits, M. (Scientific Project Staff), Dangl, A. (Admin), Zdrazil, B. (Scientific Project Staff), Jain, S. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)

1/01/1631/12/21

Project: Research funding


TransQST: Translational quantitative systems toxicology to improve the understanding of the safety of medicines

Ecker, G. (Project Lead), Grandits, M. (Admin), Dangl, A. (Admin), Füzi, B. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)

1/01/1730/06/22

Project: Research funding